Skip to main content
. 2021 May 18;8:64–71. doi: 10.18632/oncoscience.535

Figure 1. MEK5 (MAP2K5) gene expression associated with worse overall survival.

Figure 1

(A) Kaplan-Meier survival plot of MEK5 (MAP2K5) gene expression extrapolated from available RNAseq data (IlluminaHiSeq) demonstrating higher MEK5 expression is associated with worse survival probability. (B) MEK5 (MAP2K5) gene expression is inversely correlated to the TFAC30 gene signature for complete pathologic response to cytotoxic drug therapies. Data was obtained from (A) the Kaplan-Meier plotter and (B) the TCGA databases.